331 research outputs found
Iron catalysed assembly of an asymmetric mixed-ligand triple helicate
The 2-pyridinecarbaldehyde isonicotinoyl hydrazone (HPCIH) family of ligands are typically tridentate N,N,O chelators that exhibit very high in vitro activity in mobilizing intracellular Fe and are promising candidates for the treatment of Fe overload diseases. Complexation of ferrous perchlorate with HPCIH in MeCN solution gives the expected six-coordinate complex Fe-II(PCIH)(2). However, complexation of Fe-II with 2-pyridinecarbaldehyde picolinoyl hydrazone (HPCPH, an isomer of HPCIH) under the same conditions leads to spontaneous assembly of an unprecedented asymmetric, mixed-ligand dinuclear triple helical complex Fe-2(II)(PCPH)(2)(PPH), where PPH2- is the dianion of bis(picolinoyl) hydrazine. The X-ray crystal structure of this complex shows that each ligand binds simultaneously to both metal centres in a bidentate fashion. The dinuclear complex exhibits two well separated and totally reversible Fe-III/II redox couples as shown by cyclic voltammetry in MeCN solution
Mechanism of the induction of endoplasmic reticulum stress by the anti-cancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT): activation of PERK/eIF2α, IRE1α, ATF6 and calmodulin kinase
The endoplasmic reticulum (ER) plays a major role in the synthesis, maturation and folding of proteins and is a critical calcium (Ca2+) reservoir. Cellular stresses lead to an overwhelming accumulation of misfolded proteins in the ER, leading to ER stress and the activation of the unfolded protein response (UPR). In the stressful tumor microenvironment, the UPR maintains ER homeostasis and enables tumor survival. Thus, a novel strategy for cancer therapeutics is to overcome chronically activated ER stress by triggering pro-apoptotic pathways of the UPR. Considering this, the mechanisms by which the novel anti-cancer agent, Dp44mT, can target the ER stress response pathways were investigated in multiple cell-types. Our results demonstrate that the cytotoxic chelator, Dp44mT, which forms redox-active metal complexes, significantly: (1) increased ER stress-associated pro-apoptotic signaling molecules (i.e., p-eIF2α, ATF4, CHOP); (2) increased IRE1α phosphorylation (p-IRE1α) and XBP1 mRNA splicing; (3) reduced expression of ER stress-associated cell survival signaling molecules (e.g., XBP1s and p58IPK); (4) increased cleavage of the transcription factor, ATF6, which enhances expression of its downstream targets (i.e., CHOP and BiP); and (5) increased phosphorylation of CaMKII that induces apoptosis. In contrast to Dp44mT, the iron chelator, DFO, which forms redox-inactive iron complexes, did not affect BiP, p-IRE1α, XBP1 or p58IPK levels. This study highlights the ability of a novel cancer therapeutic (i.e., Dp44mT) to target the pro-apoptotic functions of the UPR via cellular metal sequestration and redox stress. Assessment of ER stress-mediated apoptosis is fundamental to the understanding of the pharmacology of chelation for cancer treatment
The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms
Abstract Background Neuroblastoma is a relatively common and highly belligerent childhood tumor with poor prognosis by current therapeutic approaches. A novel anti-cancer agent of the di-2-pyridylketone thiosemicarbazone series, namely di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), demonstrates promising anti-tumor activity. Recently, a second-generation analogue, namely di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), has entered multi-center clinical trials for the treatment of advanced and resistant tumors. The current aim was to examine if these novel agents were effective against aggressive neuroblastoma in vitro and in vivo and to assess their mechanism of action. Methods Neuroblastoma cancer cells as well as immortalized normal cells were used to assess the efficacy and selectivity of DpC in vitro. An orthotopic SK-N-LP/Luciferase xenograft model was used in nude mice to assess the efficacy of DpC in vivo. Apoptosis in tumors was confirmed by Annexin V/PI flow cytometry and H&E staining. Results DpC demonstrated more potent cytotoxicity than Dp44mT against neuroblastoma cells in a dose- and time-dependent manner. DpC significantly increased levels of phosphorylated JNK, neuroglobin, cytoglobin, and cleaved caspase 3 and 9, while decreasing IkBα levels in vitro. The contribution of JNK, NF-ÄžB, and caspase signaling/activity to the anti-tumor activity of DpC was verified by selective inhibitors of these pathways. After 3 weeks of treatment, tumor growth in mice was significantly (pâ<â0.05) reduced by DpC (4 mg/kg/day) given intravenously and the agent was well tolerated. Xenograft tissues showed significantly higher expression of neuroglobin, cytoglobin, caspase 3, and tumor necrosis factor-α (TNFα) levels and a slight decrease in interleukin-10 (IL-10). Conclusions DpC was found to be highly potent against neuroblastoma, demonstrating its potential as a novel therapeutic for this disease. The ability of DpC to increase TNFα in tumors could also promote the endogenous immune response to mediate enhanced cancer cell apoptosis
Hydrazone chelators for the treatment of iron overload disorders: iron coordination chemistry and biological activity
The potentially tridentate ligand 2-pyridinecarbaldehyde isonicotinoyl hydrazone (HPCIH) and its analogues are an emerging class of orally effective Fe chelators that show great promise for the treatment of Fe overload diseases. Herein, we present an extensive study of the Fe coordination chemistry of the HPCIH analogues including the first crystallographically characterised Fe-II complex of these chelators. Unlike most other clinically effective Fe chelators, the HPCIH analogues bind Fe-II and not F-III. In fact, these chelators form low-spin bis-ligand F-II complexes, although NMR suggests that the complexes are close to the high-spin/low-spin crossover. All the Fe complexes show a high potential Fe-III/(II) redox couple (> 500 mV vs. NHE) and cyclic voltammetry in aqueous or mixed aqueous/organic solvents is irreversible as a consequence of a rapid hydration reaction that occurs upon oxidation. A number of the HPCIH analogues show high activity at inducing Fe efflux from cells and also at preventing Fe uptake by cells from the serum Fe transport protein transferrin. As a class of ligands, these chelators are more effective at reducing Fe uptake from transferrin than inducing Fe mobilisation from cells. This may be related to their ability to intercept Fe-II after its release from transferrin within the cell. Our studies indicate that their Fe chelation efficacy is due, at least in part, to the fact that these ligands and their Fe-II complexes are neutral at physiological pH (7.4) and sufficiently lipophilic to permeate cell membranes
Heterocyclic dithiocarbazate iron chelators: Fe coordination chemistry and biological activity
The iron coordination and biological chemistry of a series of heterocyclic dithiocarbazate Schiff base ligands is reported with regard to their activity as Fe chelators for the treatment of Fe overload and also cancer. The ligands are analogous to tridentate heterocyclic hydrazone and thiosemicarbazone chelators we have studied previously which bear NNO and NNS donor sets. The dithiocarbazate Schiff base ligands in this work also are NNS chelators and form stable low spin ferric and ferrous complexes and both have been isolated. In addition an unusual hydroxylated ligand derivative has been identified via an Fe-induced oxidation reaction. X-ray crystallographic and spectroscopic characterisation of these complexes has been carried out and also the electrochemical properties have been investigated. All Fe complexes exhibit totally reversible Fe couples in mixed aqueous solvents at potentials higher than found in analogous thiosemicarbazone Fe complexes. The ability of the dithiocarbazate Schiff base ligands to mobilise Fe from cells and also to prevent Fe uptake from transferrin was examined and all ligands were effective in chelating intracellular Fe relative to known controls such as the clinically important Fe chelator desferrioxamine. The Schiff base ligands derived from 2-pyridinecarbaldehyde were non-toxic to SK-N-MC neuroepithelioma (cancer) cells but those derived from the ketones 2-acetylpyridine and di-2-pyridyl ketone exhibited significant antiproliferative activity
30 days wild: development and evaluation of a large-scale nature engagement campaign to improve well-being
There is a need to increase peopleâs engagement with and connection to nature, both for human well-being and the conservation of nature itself. In order to suggest ways for people to engage with nature and create a wider social context to normalise nature engagement, The Wildlife Trusts developed a mass engagement campaign, 30 Days Wild. The campaign asked people to engage with nature every day for a month. 12,400 people signed up for 30 Days Wild via an online sign-up with an estimated 18,500 taking part overall, resulting in an estimated 300,000 engagements with nature by participants. Samples of those taking part were found to have sustained increases in happiness, health, connection to nature and pro-nature behaviours. With the improvement in health being predicted by the improvement in happiness, this relationship was mediated by the change in connection to nature
A comparative study of the antiprolifrative activity of thiosemicarbazone iron chelators in skin cells
Transiting Exoplanets with JWST
The era of exoplanet characterization is upon us. For a subset of exoplanets
-- the transiting planets -- physical properties can be measured, including
mass, radius, and atmosphere characteristics. Indeed, measuring the atmospheres
of a further subset of transiting planets, the hot Jupiters, is now routine
with the Spitzer Space Telescope. The James Webb Space Telescope (JWST) will
continue Spitzer's legacy with its large mirror size and precise thermal
stability. JWST is poised for the significant achievement of identifying
habitable planets around bright M through G stars--rocky planets lacking
extensive gas envelopes, with water vapor and signs of chemical disequilibrium
in their atmospheres. Favorable transiting planet systems, are, however,
anticipated to be rare and their atmosphere observations will require tens to
hundreds of hours of JWST time per planet. We review what is known about the
physical characteristics of transiting planets, summarize lessons learned from
Spitzer high-contrast exoplanet measurements, and give several examples of
potential JWST observations.Comment: 22 pages, 11 figures. In press in "Astrophysics in the Next Decade:
JWST and Concurrent Facilities, Astrophysics & Space Science Library,
Thronson, H. A., Tielens, A., Stiavelli, M., eds., Springer: Dordrecht
(2008)." The original publication will be available at
http://www.springerlink.co
The chemistry of C3 & Carbon Chain Molecules in DR21(OH)
(Abridged) We have observed velocity resolved spectra of four ro-vibrational
far-infrared transitions of C3 between the vibrational ground state and the
low-energy nu2 bending mode at frequencies between 1654--1897 GHz using HIFI on
board Herschel, in DR21(OH), a high mass star forming region. Several
transitions of CCH and c-C3H2 have also been observed with HIFI and the IRAM
30m telescope. A gas and grain warm-up model was used to identify the primary
C3 forming reactions in DR21(OH). We have detected C3 in absorption in four
far-infrared transitions, P(4), P(10), Q(2) and Q(4). The continuum sources MM1
and MM2 in DR21(OH) though spatially unresolved, are sufficiently separated in
velocity to be identified in the C3 spectra. All C3 transitions are detected
from the embedded source MM2 and the surrounding envelope, whereas only Q(4) &
P(4) are detected toward the hot core MM1. The abundance of C3 in the envelope
and MM2 is \sim6x10^{-10} and \sim3x10^{-9} respectively. For CCH and c-C3H2 we
only detect emission from the envelope and MM1. The observed CCH, C3, and
c-C3H2 abundances are most consistent with a chemical model with
n(H2)\sim5x10^{6} cm^-3 post-warm-up dust temperature, T_max =30 K and a time
of \sim0.7-3 Myr. Post warm-up gas phase chemistry of CH4 released from the
grain at t\sim 0.2 Myr and lasting for 1 Myr can explain the observed C3
abundance in the envelope of DR21(OH) and no mechanism involving
photodestruction of PAH molecules is required. The chemistry in the envelope is
similar to the warm carbon chain chemistry (WCCC) found in lukewarm corinos.
The observed lower C3 abundance in MM1 as compared to MM2 and the envelope
could be indicative of destruction of C3 in the more evolved MM1. The timescale
for the chemistry derived for the envelope is consistent with the dynamical
timescale of 2 Myr derived for DR21(OH) in other studies.Comment: 11 Pages, 6 figures, accepted for publication in A&
- âŠ